IBS (irritable bowel syndrome) affects an estimated 1 in 5 adults in the UK, making it one of the most common gastrointestinal conditions seen by GPs. Despite its prevalence, IBS remains poorly understood mechanistically, and conventional treatment options are limited. Probiotics have emerged as one of the most evidence-supported natural interventions for IBS symptom management — but the research is highly strain-specific. Taking any probiotic and expecting IBS benefits is like taking any painkiller and expecting it to work on every type of pain. This guide explains which strains have genuine clinical evidence, in what doses and for which IBS subtypes.
IBS Types and Why They Matter for Probiotic Selection
IBS is classified into four subtypes based on dominant bowel habit:
- IBS-D (diarrhoea-predominant) — loose, frequent stools
- IBS-C (constipation-predominant) — infrequent, hard stools
- IBS-M (mixed) — alternating between diarrhoea and constipation
- IBS-U (unclassified) — IBS symptoms without a clear bowel habit pattern
Different probiotic strains show stronger evidence for different subtypes. Identifying your subtype helps target supplementation more precisely.
Which Probiotic Strains Have Evidence for IBS?
Lactobacillus acidophilus
L. acidophilus is the most extensively studied probiotic strain for IBS overall. Multiple randomised controlled trials show significant reductions in abdominal pain, bloating and stool irregularity with L. acidophilus supplementation across IBS subtypes. It appears to work through multiple mechanisms: normalising gut motility, reducing intestinal permeability (leaky gut), competing with pathogenic bacteria for adhesion sites on the gut wall and modulating the gut-brain axis signalling involved in visceral hypersensitivity — the technical term for the exaggerated pain response to normal gut sensations that characterises IBS.
Bifidobacterium infantis
B. infantis 35624 has been studied specifically in IBS-D in a large multicentre trial involving over 360 patients. The trial found significant improvements in abdominal pain, bloating and bowel habit normalisation compared to placebo — with the response maintained over 8 weeks of supplementation. B. infantis is now considered one of the best-evidenced single strains for IBS overall.
Lactobacillus rhamnosus GG
L. rhamnosus GG has strong evidence specifically for IBS-D and post-infectious IBS (IBS that develops following a gut infection — accounting for approximately 10–15% of all IBS cases). It reduces intestinal permeability, normalises stool frequency and has anti-inflammatory effects on the gut mucosa.
Bifidobacterium lactis
B. lactis shows particular benefit for IBS-C, where it improves gut transit time and stool consistency. Combined with L. acidophilus in multi-strain formulas, it provides coverage across the full IBS symptom spectrum.
Saccharomyces boulardii
S. boulardii — the probiotic yeast — has specific evidence for IBS-D, reducing loose stool frequency and improving stool consistency. Its antibiotic resistance makes it the only probiotic that remains active during antibiotic courses — particularly relevant for post-antibiotic IBS, which is common after gut flora disruption.
What CFU Count Do You Need for IBS?
CFU count matters significantly for IBS symptom management. Most IBS clinical trials showing benefit used doses of 5–40 billion CFU daily — substantially higher than the 1–4 billion CFU found in many supermarket probiotics. For active IBS symptom management, aim for a minimum of 10 billion CFU from clinically relevant strains. A 20 billion CFU multi-strain formula provides a more robust intervention than lower-dose products.
BioBodyBoost Probiotic Options for IBS
BioTic 20 Billion provides 20 billion CFU across multiple clinically relevant strains including Lactobacillus acidophilus and Bifidobacterium lactis — suited to active IBS symptom management where a higher CFU count and multi-strain coverage are indicated. Halal certified, kosher, vegan, dairy-free and UK-made.
For IBS-D specifically, or for use during and after antibiotic courses, SaccharoMyTum provides clinical-dose S. boulardii with vitamin D3 — antibiotic-resistant and directly relevant to diarrhoea-predominant IBS and post-antibiotic gut recovery.
For sensitive stomachs or as a daily maintenance formula, BioTic 4 Billion provides 4 billion CFU in a lower-dose multi-strain formula better tolerated by those who experience digestive adjustment on higher-dose products. Explore the full Gut Health UK collection.
How Long Do Probiotics Take to Work for IBS?
Clinical trials showing benefit typically run for 4–8 weeks. Initial improvements in bloating and urgency are often noticeable within 2–3 weeks, with more consistent symptom improvement building over the full 4–8 week period. Probiotics need to be taken consistently daily — missing doses disrupts the colonisation process. For ongoing IBS management, continuous daily supplementation is more effective than short courses.
